Zoetis Inc. logo ZTS - Zoetis Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 15
HOLD 14
SELL 0
STRONG
SELL
0
| PRICE TARGET: $125.71 DETAILS
HIGH: $160.00
LOW: $95.00
MEDIAN: $135.00
CONSENSUS: $125.71
UPSIDE: 54.59%

About Zoetis Inc. (https://www.zoetis.com)

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites, which include fleas, ticks, and worms. It also provides other pharmaceutical products that comprise pain and sedation, antiemetic, reproductive, and oncology products; dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives, which offer medicines to livestock. In addition, the company provides portable blood and urine analysis testing, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision animal health. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.

Key Executives

NAME TITLE DOB SALARY
Kristin C. Peck Chief Executive Officer & Director 1971 $5,421,697 USD
Wetteny N. Joseph Executive Vice President & Chief Financial Officer 1972 $1,796,941 USD
Jamie Brannan Executive Vice President & Chief Commercial Officer 1974 $1,742,448 USD
Robert J. Polzer Scientific Advisor 1970 $1,445,441 USD
Roxanne Lagano Executive Vice President, General Counsel & Corporate Secretary 1965 $1,435,587 USD
Jared Shriver President of U.S. Operations
Jeannette Ferran Astorga Executive Vice President of Corporate Affairs & Chief Sustainability Officer 1976
Julie A. Fuller Executive Vice President, Chief Human Resources Officer & Global Operations 1973
Keith Sarbaugh Executive Vice President & Chief Digital and Technology Officer 1979
Nick Ashton Executive Vice President and President of Global Manufacturing & Supply 1974
Rimma Driscoll EVP of Global Strategy, Portfolio Mktg. & Business Dev and Global BioDevices & Platinum Performance 1973
Steven Frank Vice President of Investor Relations

Company Peers

Peer analysis pending, check back in 1-2 minutes.